Roses are red,
violets are blue,
the brain keeps a gate,
and hormones do too.
That sounds like something stitched onto a pillow by a neuroendocrinologist with a suspiciously large herb garden, but it is also the basic plot of a new glioblastoma story. A Cancer Discovery Research Watch item highlighted a Nature study with a counterintuitive finding: in male glioblastoma, losing androgen signaling may help the tumor grow faster, while preserving it may keep some of the brain’s immune gardening crew on task [1,2].
Glioblastoma is the invasive bindweed of brain cancers. It does not politely stay in one bed with a little label stuck beside it. It threads into surrounding brain tissue, resists many treatments, and tends to return even after surgery, radiation, and temozolomide, the standard chemotherapy workhorse that keeps showing up with muddy boots and a tired face.
For years, many scientists looked at the male bias in glioblastoma and wondered whether testosterone was feeding the weed patch. Reasonable thought. Androgens can stimulate some cancers, and androgen receptor signaling has been explored as a possible glioblastoma target [3,4]. In prostate cancer, cutting androgen signaling is basically precision pruning with very serious clippers. So naturally, one might expect the same strategy to help in brain tumors.
Nature, because it enjoys making tidy theories trip over a root, had other plans.
The Brain Is Not Just Another Flower Bed
Lee and colleagues studied androgen loss in mouse models of glioblastoma and found something odd: removing androgens by castration accelerated tumor growth inside the brain, even though the opposite pattern appeared in tumors growing outside the brain [2]. Same hormonal pruning shears, different patch of soil.
The proposed explanation runs through the hypothalamus-pituitary-adrenal axis, or HPA axis, which is the body’s stress-hormone irrigation system. When androgen levels dropped in male mice with brain tumors, the HPA axis became more active. Glucocorticoids rose. Those stress hormones then helped myeloid immune cells create a more suppressive tumor microenvironment, the sort of shady corner where immune attack gets damp, sluggish, and slightly embarrassed to be there.
T cells, which should be pulling weeds with righteous fury, showed signs of dysfunction. The immune garden crew did not disappear, exactly. It just looked like somebody replaced their tools with decorative spoons.
The Human Clue
The human part of the Nature study was observational, which means nobody should read it as “testosterone treats brain cancer.” Please do not sprint into your doctor’s office waving a hormone bottle like a victory turnip.
But the signal was interesting. In a SEER-Medicare analysis of more than 1,300 men with glioblastoma, those receiving supplemental testosterone along with temozolomide had longer median overall survival than men receiving temozolomide without testosterone: 16 months versus 12 months. The reported hazard ratio suggested a 38% lower risk of death before full adjustment, and a 34% lower risk after adjustment [2]. That does not prove cause and effect, but it does raise a sturdy little flag in the soil.
NIH’s coverage framed the result as a “welcome surprise,” and the surprise is the whole point: the brain has its own immune rules, its own barriers, and its own nervous little weather patterns [5]. A treatment idea that makes sense in one cancer ecosystem may behave very differently once it crosses into the central nervous system.
Why This Matters
Glioblastoma badly needs new angles. Current therapies can slow the disease, but the tumor often regrows from cells left behind in the brain’s delicate terrain. Immunotherapy has changed the landscape for melanoma, lung cancer, and other cancers, yet glioblastoma remains a stubborn, walled garden where immune cells often cannot work well.
This study suggests that androgen signaling may help preserve neuroimmune balance in males with brain tumors. That is not the same as saying “more testosterone is better.” Biology is not a lawn sprinkler with two settings. Earlier work has also reported tumor-promoting effects of testosterone in glioma models, including increased GDNF-linked inflammation and glioma cell survival [6]. A 2026 review described testosterone in glioblastoma as genuinely dual-use: capable of influencing tumor cells, the microenvironment, and neuroprotection in different directions depending on context [7].
In plain terms: testosterone may be less like fertilizer and more like garden weather. A warm rain can help the tomatoes. It can also wake every weed seed in the county. Location, dose, timing, cell type, and immune context matter.
The Next Rows to Plant
If this result holds up, it could change how researchers think about sex hormones in glioblastoma. It may prompt clinical trials testing whether carefully managed androgen signaling can support standard therapy or protect antitumor immunity in selected male patients. It may also make doctors look more closely at androgen deprivation, low testosterone, stress hormones, and immune suppression in men with brain tumors.
The bigger lesson is humbling in the best way. Cancer biology is not one garden. It is many gardens, each with different soil, fences, pests, and weather. Glioblastoma grows in the brain, and the brain is a fussy greenhouse with security guards, velvet ropes, and a thermostat nobody fully understands.
Still, this work gives researchers a new spade. Not a cure. Not a shortcut. But a sharper way to ask why the immune system sometimes loses its grip in glioblastoma, and how preserving the brain’s own neuroimmune order might keep the weeds from taking over quite so fast.
References
-
Cancer Discovery Research Watch. Androgen Signaling Limits Glioblastoma Growth by Preserving Neuroimmune Functions in the Brain. Cancer Discovery. 2026. DOI: 10.1158/2159-8290.CD-RW2026-053
-
Lee J, Chung YM, Silver DJ, et al. Androgen loss accelerates brain tumour growth via HPA axis activation. Nature. 2026;653:1184-1195. DOI: 10.1038/s41586-026-10451-5. PMCID: PMC13216072
-
Quintero JC, Alemán OR, Camacho-Arroyo I. Targeting sex hormone signaling: A promising therapeutic alternative for glioblastoma. Biochim Biophys Acta Rev Cancer. 2025;1880(6):189486. DOI: 10.1016/j.bbcan.2025.189486
-
Bryukhovetskiy I, Kosianova A, Zaitsev S, Pak O, Polevshchikov A. The duality of testosterone in glioblastoma: From targeted therapy to modulation of the tumor microenvironment and neuroprotection. Biomed Pharmacother. 2026;200:119483. DOI: 10.1016/j.biopha.2026.119483
-
National Institutes of Health. NIH-funded study suggests that testosterone suppresses brain tumor growth in males. May 6, 2026. https://www.nih.gov/news-events/news-releases/nih-funded-study-suggests-testosterone-suppresses-brain-tumor-growth-males
-
Kanwore K, et al. Testosterone upregulates glial cell line-derived neurotrophic factor (GDNF) and promotes neuroinflammation to enhance glioma cell survival and proliferation. Inflammation and Regeneration. 2023;43:49. DOI: 10.1186/s41232-023-00300-7
Disclaimer: The image accompanying this article is for illustrative purposes only and does not depict actual experimental results, data, or biological mechanisms.